AN AUTOPSY CASE OF CLASSICAL HEMIZYGOUS FABRY DISEASE ON HEMODIALYSIS DEMONSTRATING IRREVERSIBLE ORGAN DAMAGE

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/8aa3523d78ea5a6f586bf8f717dd446d.pdf
AN AUTOPSY CASE OF CLASSICAL HEMIZYGOUS FABRY DISEASE ON HEMODIALYSIS DEMONSTRATING IRREVERSIBLE ORGAN DAMAGE

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Takashi
Morikawa
Takashi Morikawa konitiha.morikawa@gmail.com Osaka City General Hospital Department of Nephrology and Hypertension Osaka Japan *
Katsushi Nagatsuji ka_a_chan0616@yahoo.co.jp Osaka City General Hospital Department of Nephrology and Hypertension Osaka Japan -
Junpei Hosotani hosotanijun0811.iriomote11@gmail.com Osaka City General Hospital Department of Nephrology and Hypertension Osaka Japan -
Yumi Sakaguchi grashel.yumi@gmail.com Osaka City General Hospital Department of Nephrology and Hypertension Osaka Japan -
Kiyotaka Sumi kiyotakasumi6023@outlook.com Osaka City General Hospital Department of Nephrology and Hypertension Osaka Japan -
Eriko Sakai sakair0128@gmail.com Osaka City General Hospital Department of Nephrology and Hypertension Osaka Japan -
Natsuki Ide natuki8717@gmail.com Osaka City General Hospital Department of Nephrology and Hypertension Osaka Japan -
Aoi Matsuki ma2ki55kmmn@gmail.com Osaka City General Hospital Department of Nephrology and Hypertension Osaka Japan -
Keita Kadosawa keita1913@yahoo.co.jp Osaka City General Hospital Department of Nephrology and Hypertension Osaka Japan -
Yuko Inoue yuko.28.cherry@gmail.com Osaka City General Hospital Department of Nephrology and Hypertension Osaka Japan -
Daisuke Yamazaki proximaltuble@yahoo.co.jp Osaka City General Hospital Department of Nephrology and Hypertension Osaka Japan -
Masahiro Hamada masahiro19811220@yahoo.co.jp Osaka City General Hospital Department of Nephrology and Hypertension Osaka Japan -
Chizuko Kitabayashi hellokit_109@yahoo.co.jp Osaka City General Hospital Department of Nephrology and Hypertension Osaka Japan -
Takeshi Inoue tak-inoue@med.osakacity-hp.or.jp Osaka City General Hospital Department of Pathology Osaka Japan -
Yoshio Konishi y-konishi@med.osakacity-hp.or.jp Osaka City General Hospital Department of Nephrology and Hypertension Osaka Japan -